Search

Author/Creator Kumar, Birendra

4. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9 (September 2022)

Authors:
Powles, Thomas; Tomczak, Piotr; Park, Se Hoon; Venugopal, Balaji; Ferguson, Thomas; Symeonides, Stefan N; Hajek, Jaroslav; Gurney, Howard; Chang, Yen-Hwa; Lee, Jae Lyun; Sarwar, Naveed; Thiery-Vuillemin, Antoine; Gross-Goupil, Marine; Mahave, Mauricio; Haas, Naomi B; Sawrycki, Piotr; Burgents, Jo...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 9(2022)
Page Start:
1133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Insilico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (Mpro) structure of SARS-CoV-2. Issue 17 (22nd November 2022)

Authors:
Kumar, Birendra; Parasuraman, P.; Murthy, Thirupathihalli Pandurangappa Krishna; Murahari, Manikanta; Chandramohan, Vivek
Journal:
Journal of biomolecular structure & dynamics
Issue:
Volume 40:Issue 17(2022)
Page Start:
7796
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Influence of Potassium and Sodium chloride on Germination Behaviour, Biochemical Changes, and Enzyme Activity in Two Varieties of Ocimum tenuiflorum L. Issue 1 (2nd January 2021)

Authors:
Gupta, Akancha; Singh, Vagmi; Prasad, Priyanka; Kumar, Mukesh; Srivastava, Aishwarya; Singh, Vivek; Luqman, Suaib; Kumar, Birendra
Journal:
Journal of essential oil-bearing plants
Issue:
Volume 24:Issue 1(2021)
Page Start:
110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗